Skip to main content
OpenTrials
Completed

NCT Number: NCT07740473

Therapeutic Effects of Cinnamon-Enriched Cookies on Hypercholesterolemia and Liver Function

Cinnamon-enriched cookies were developed and evaluated for their sensory acceptability and potential as a functional food for adults with hyperlipidemia. The findings suggest that incorporating cinnamon into cookies alongside conventional therapy may support cardiovascular and liver health while offering a palatable dietary intervention.

Completed

Looking for future studies?

Notify Me

Key information

Age range

45 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sana Noreen

Lahore, Punjab Province, 54000, Pakistan

About this study

This study developed cinnamon-enriched cookies as a functional food and evaluated their sensory acceptability, physical characteristics, and potential health benefits in adults with hyperlipidemia receiving conventional therapy. The findings highlight the potential of cinnamon-enriched cookies as a convenient, acceptable, and food-based dietary strategy to support cardiovascular and liver health, encouraging the development of functional bakery products for managing hyperlipidemia.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Both men and women aged 45-55 participated in the study. The experiment targeted high-cholesterol, triglycerides, and low-density lipoprotein patients (>220, 150, and 130 mg/dL).

Exclusion criteria

Individuals with diabetes, gastrointestinal issues, documented cinnamon allergies were excluded.

-

Treatment and study plan

Treatment group T1

Dietary Supplement

Conventional therapy + cinnamon-enriched cookie (1 cookie/day)

Primary outcomes

  1. Anthropometric measurement

    Time frame: 10 weeks

    Weight, BMI was measured

  2. Lipid Profile

    Time frame: 10 weeks

    Lipid Profile was observed

Secondary outcomes

  1. Liver Enzymes

    Time frame: 10 weeks

    Liver Enzymes were observed

Sponsors and collaborators

Lead sponsor

University of Lahore

Other

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jul 31, 2026
Registry last updated
Jul 31, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.